NCT00338351View on ClinicalTrials.gov

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

PHASE2CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

October 31, 2006

Conditions

Hepatitis A

Interventions

BIOLOGICAL

Pneumococcal (vaccine)

Trial Locations (1)

Unknown

GSK Investigational Site, Santiago

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00338351 - Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. | Biotech Hunter | Biotech Hunter